Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data

INTRODUCTION: There is a paucity of data on how patient characteristics may affect the long-term durability of certolizumab pegol (CZP) in patients with rheumatoid arthritis (RA). This study therefore aimed to investigate CZP durability and reasons for discontinuation over 5 years between different...

Descripción completa

Detalles Bibliográficos
Autores principales: Bykerk, Vivian P., Nash, Peter, Nicholls, David, Tanaka, Yoshiya, Winthrop, Kevin, Popova, Christina, Tilt, Nicola, Haaland, Derek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140240/
https://www.ncbi.nlm.nih.gov/pubmed/36848009
http://dx.doi.org/10.1007/s40744-023-00541-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140240/
https://www.ncbi.nlm.nih.gov/pubmed/36848009
http://dx.doi.org/10.1007/s40744-023-00541-5

Ejemplares similares